The European Medicines Agency is continuing to receive a fair number of applications for a place on its PRIME (priority medicines) scheme for getting drugs for unmet needs to patients faster, but it is still rejecting most of them.
Of the 14 applications that were submitted in the first two months of 2019, only two made the grade.








